Clinical Trial

Evaluating the Pharmacokinetics of Oregano and Potential Oregano-drug Interactions Using a Drug Cocktail Approach

Name: Evaluating the Pharmacokinetics of Oregano and Potential Oregano-drug Interactions Using a Drug Cocktail Approach — clinical trial record (NCT06693960)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this clinical trial is to determine how the supplement oregano affects how the body metabolizes pharmaceutical drugs.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2024-11-15; most recent amendment 2026-06-02.

Trial Details

NCT Number	NCT06693960
Lead Sponsor	Washington State University Collaborators: Office of Dietary Supplements (ODS), National Center for Complementary and Integrative Health (NCCIH)
Conditions	Interaction
Enrollment	16 participants
Start Date	2024-09-26
Primary Completion	2026-12-15 (estimated)
Study Completion	2027-01-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-04